The Breast Cancer Research Foundation
BCRF Healthologysend an e-cardsupport our partners

resourcespresscontact usdonate now
about BCRFresearch in actionpartners & programseventsget involved
emailprint

Breast Cancer Breast Cancer Treatment


When new drugs are tested, patients sometimes receive a “dummy pill.”


Clinical trials must be performed before a drug can be recommended to the general public. These studies usually involve giving one group of patients the drug being investigated and another group an inactive substance called a placebo. This enables investigators to see if the drug is safe and effective. Sometimes the patients and the study investigators are unaware of who is taking the drug and who is taking the placebo. Investigators try to make sure that the people in both groups are similar in terms of age, type of disease and past treatment history, so that the trial results are as valid as possible.

Trials are usually designed to last for a set period of time that will allow the investigators to gather enough information about the drug’s safety and effectiveness. Although it is rare, studies can be halted early if a drug appears to be working well. This way doctors can offer all patients the opportunity to benefit from the drug.

RELATED PROGRAMS
Video - How to Make Sense of Clinical Trials Transcript



HealthVideo.com © 2008 NBC Digital Health Network, Inc. All Rights Reserved
Privacy Policy - Disclaimer - Editorial Policy
We subscribe to the HONcode principles.
HonCode Logo
Verify here

join our mailing listsend an e-cardsupport our partners


homesite mapsearchtermsprivacy policycontact us© 2007 The Breast Cancer Research Foundation